Prestige Consumer Healthcare Inc (PBH)
69.94
-0.06
(-0.09%)
USD |
NYSE |
May 07, 16:00
69.94
0.00 (0.00%)
After-Hours: 19:33
Prestige Consumer Healthcare Free Cash Flow: 232.04M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 232.04M |
| September 30, 2023 | 215.70M |
| June 30, 2023 | 211.34M |
| March 31, 2023 | 221.93M |
| December 31, 2022 | 225.47M |
| September 30, 2022 | 236.40M |
| June 30, 2022 | 239.68M |
| March 31, 2022 | 250.28M |
| December 31, 2021 | 244.51M |
| September 30, 2021 | 223.94M |
| June 30, 2021 | 208.57M |
| March 31, 2021 | 213.36M |
| December 31, 2020 | 209.79M |
| September 30, 2020 | 221.06M |
| June 30, 2020 | 224.34M |
| March 31, 2020 | 202.56M |
| December 31, 2019 | 199.45M |
| September 30, 2019 | 185.95M |
| June 30, 2019 | 176.24M |
| March 31, 2019 | 178.80M |
| December 31, 2018 | 182.86M |
| September 30, 2018 | 183.86M |
| June 30, 2018 | 199.39M |
| March 31, 2018 | 197.58M |
| December 31, 2017 | 152.50M |
| Date | Value |
|---|---|
| September 30, 2017 | 149.77M |
| June 30, 2017 | 146.86M |
| March 31, 2017 | 145.70M |
| December 31, 2016 | 178.04M |
| September 30, 2016 | 183.51M |
| June 30, 2016 | 180.41M |
| March 31, 2016 | 172.74M |
| December 31, 2015 | 183.62M |
| September 30, 2015 | 183.38M |
| June 30, 2015 | 163.72M |
| March 31, 2015 | 150.15M |
| December 31, 2014 | 131.06M |
| September 30, 2014 | 111.22M |
| June 30, 2014 | 116.56M |
| March 31, 2014 | 108.82M |
| December 31, 2013 | 113.58M |
| September 30, 2013 | 125.51M |
| June 30, 2013 | 135.23M |
| March 31, 2013 | 127.34M |
| December 31, 2012 | 111.16M |
| September 30, 2012 | 88.80M |
| June 30, 2012 | 65.02M |
| March 31, 2012 | 66.85M |
| December 31, 2011 | 72.40M |
| September 30, 2011 | 76.61M |
Free Cash Flow Range, Past 5 Years
176.24M
Minimum
Jun 2019
250.28M
Maximum
Mar 2022
218.03M
Average
221.06M
Median
Sep 2020
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 71.47M |
| Cash from Investing (Quarterly) | -4.496M |
| Cash from Financing (Quarterly) | -64.84M |
| Free Cash Flow Per Share (Quarterly) | 1.386 |
| Free Cash Flow to Equity (Quarterly) | 133.11M |
| Free Cash Flow to Firm (Quarterly) | 82.11M |
| Free Cash Flow Yield | 6.63% |